FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068440 [Registered on: 06/06/2024] Trial Registered Prospectively
Last Modified On: 09/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to study the effect of punarnavashtak kwath in patients with iron deficiency anemia 
Scientific Title of Study   Clinical evaluation of the efficacy of punnarnavashtak kwath in the management of pandu rog w.s.r. to iron deficiency anaemia - a randomized controlled trial. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Aniket Purushottam Raut  
Designation  PG Scholar (Kayachikitsa) 
Affiliation  Radhakisan Toshniwal Ayurved Mahavidyalaya, Akola  
Address  Room no.1, Kayachikitsa Department, Radhakisan Towshniwal Ayurved Mahavidyalaya, Kediya plots, Jatharpeth Road, Akola

Akola
MAHARASHTRA
444005
India 
Phone  8624898662  
Fax    
Email  aniketraut101@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Sadhana Ashutosh Kulkarni 
Designation  HOD and Professor (Kayachikitsa ) 
Affiliation  Radhakisan Toshniwal Ayurved Mahavidyalaya, Akola  
Address  Room no.1, Kayachikitsa Department, Radhakisan Toshniwal Ayurved Mahavidyalaya, Kediya Plots, Jatharpeth Road, Akola

Akola
MAHARASHTRA
444005
India 
Phone  9422939510  
Fax    
Email  drsadhana.k@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Aniket Purushottam Raut  
Designation  PG Scholar (Kayachikitsa) 
Affiliation  Radhakisan Toshniwal Ayurved Mahavidyalaya, Akola  
Address  Room no.1, Kayachikitsa Department, Radhakisan Toshniwal Ayurved Mahavidyalaya, Kediya Plots, Jatharpeth Road, Akola

Akola
MAHARASHTRA
444005
India 
Phone  8624898662  
Fax    
Email  aniketraut101@gmail.com  
 
Source of Monetary or Material Support  
Radhakisan Toshniwal Ayurved Hospital , Akola 
 
Primary Sponsor  
Name  Dr Aniket Purushottam Raut  
Address  Room no.1, Kayachikitsa Department, Radhakisan Toshniwal Ayurved Mahavidyalaya, Kediya Plots, Jatharpeth Road, Akola 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aniket Purushottam Raut   Radhakisan Toshniwal Ayurved Hospital  Room no.1, Kayachikitsa Department, Kediya Plots,Jatharpeth Road, Akola
Akola
MAHARASHTRA 
8624898662

aniketraut101@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
R. T. Ayurved Mahavidyalaya Akola   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D509||Iron deficiency anemia, unspecified. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Punarnavashtak kwatha, Reference: Bhaishajya ratnavali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 40 Days, anupAna/sahapAna: No, Additional Information: - Follow up of each patient after every 10 days (for 60 days)
2Comparator ArmDrugClassical(1) Medicine Name: Vasadi kwatha, Reference: Bhaishajya ratnavali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 40 Days, anupAna/sahapAna: Yes(details: - Madhu), Additional Information: - Follow up of each patient after every 10 days (for 60 days)
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Patients presenting with classical signs and symptoms of Pandu Rog i.e. Panduta, Daurbalya, Aruchi, Aalaysa, Shwas , Hridyaspandan and Gatrashool will be selected . Minimum 4 symptoms from above will be included .
2) Age with age group 18 – 60 yrs.
3) Haemoglobin level - below 12 gm/dl in Female and below 13 gm/dl in Male
4) Serum Ferritin - below 30 ng/ml in Female and below 50 ng/ml in Male
5) Patients will be selected irrespective of Gender , Occupation and Socioeconomic status .  
 
ExclusionCriteria 
Details  1) Age less than 18 yrs and more than 60 yrs. 2) Haemoglobin level below 5 gm/dl
3) Pregnant and lactating mother
4) Any Bleeding Disorders e.g. Haematemesis , Bleeding Piles etc.
5) Anaemia other than Iron Deficiency Anaemia . 6) Severe Renal / Hepatic / Cardiac disease
7) Those Patients not willing for trial and not giving written consent .  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Improvement Hb%
1. Marked Increased greater than or equal to 1.5 gm/dl
2. Moderate Increased by 1 to 1.4 gm/dl
3. Mild Increased by 0.5 to 0.9 gm/dl
4. Poor Increased by 0 to 0.4 gm/dl

Improvement Serum Ferritin
1. Marked Increase greater than 3 ng/dl
2. Moderate Increase by 2.1 to 3 ng/dl
3. Mild Increase by 1.1 to 2 ng/dl
4. Poor Increase by 0 to 1 ng/dl 
2 months  
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in subjective parameters such as
1) Panduta ( Pallor ) 2) Daurabalya ( Weakness ) 3) Aruchi ( Anorexia ) 4) Aalaysa ( Inactivity) 5) Shwas (Dyspnoea) 6) Hrudyaspandan (Palpitation) 7) Gatrashula ( Bodyache)  
2 months  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   17/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a randomized , single blind , parallel group , controlled trial to evaluate punarnavashtak Kwath is more efficative than Vasadi Kwath in the management of Pandu Rog w.s.r. to Iron Deficiency Anemia for 12 months in 60 patients will be conducted in India . The primary outcome measures improvement in Hemoglobin percentage and serum Ferritin level . The secondary outcome measures improvement in subjective parameters such as Panduta , Daurbalya ,  Aruchi , Aalasya , Shwas , Hridyaspandan , Gatrashoola .   
Close